HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20% cream

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W), HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY), TACROLIMUS (UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J)

Pieejams no:

Sincerus Florida, LLC

Ievadīšanas:

TOPICAL

Receptes veids:

PRESCRIPTION DRUG

Autorizācija statuss:

unapproved drug other

Produkta apraksts

HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%-
HYALURONIC ACID
SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20% CREAM
SINCERUS FLORIDA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
DIRECTIONS FOR USE
SINCERUS FLORIDA, LLC. ADVERSE REACTIONS
ACTIVE, INACTIVE
NDC 72934- 2097-2 HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS USP 0.1%
/
UREA USP 20%. CREAM 30GM.
HYALURONIC ACID SODIUM SALT 1% / TACROLIMUS 0.1% / UREA 20%
hyaluronic acid sodium salt 1% / tacrolimus 0.1% / urea 20% cream
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-20 9 7
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
UREA (UNII: 8 W8 T178 47W) (UREA - UNII:8 W8 T178 47W)
UREA
20 g in 10 0 g
HYALURO NATE SO DIUM (UNII: YSE9 PPT4TH) (HYALURONIC ACID -
UNII:S270 N0 TRQY)
HYALURONATE SODIUM
1 g in 10 0 g
TACRO LIMUS (UNII: WM0 HAQ4WNM) (TACROLIMUS ANHYDROUS -
UNII:Y5L2157C4J)
TACROLIMUS
ANHYDROUS
0 .1 g
in 10 0 g
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
Sincerus Florida, LLC
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:729 34-20 9 7-
2
30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/17/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/17/20 19
LABELER -
Sincerus Florida, LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida, LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-20 9 7)
Revised: 5/2019